Virtusa Corporation
(VRTU)
Monteverde & Associates Announces the Investigation of Virtusa Corporation
Trine Acquisition Corp.
(TRNE)
Monteverde & Associates Announces the Investigation of Trine Acquisition Corp.
Aimmune Therapeutics, Inc.
(AIMT)
Monteverde & Associates Announces the Investigation of Aimmune Therapeutics, Inc.
Immunomedics, Inc.
(IMMU)
Monteverde & Associates Announces the Investigation of Immunomedics, Inc.
BMC Stock Holdings, Inc.
(BMCH)
Monteverde & Associates Announces the Investigation of BMC Stock Holdings, Inc.
Akcea Therapeutics, Inc.
(AKCA)
Monteverde & Associates Announces the Investigation of Akcea Therapeutics, Inc.
Rosetta Stone Inc.
(RST)
Monteverde & Associates Announces the Investigation of Rosetta Stone Inc.
OncBioMune Pharmaceuticals, Inc.
(OBMP)
Monteverde & Associates Announces the Investigation of OncBioMune Pharmaceuticals, Inc.
Broadway Financial Corporation
(BYFC)
Monteverde & Associates Announces the Investigation of Broadway Financial Corporation
Proteostasis Therapeutics, Inc
(PTI)
Monteverde & Associates Announces the Investigation of Proteostasis Therapeutics, Inc
Cancer Genetics, Inc.
(CGIX)
Monteverde & Associates Announces the Investigation of Cancer Genetics, Inc.
Yintech Investment Holdings Limited
(YIN)
Monteverde & Associates Announces the Investigation of Yintech Investment Holdings Limited
Momenta Pharmaceuticals, Inc.
(MNTA)
Monteverde & Associates Announces the Investigation of Momenta Pharmaceuticals, Inc.
NTN Buzztime, Inc.
(NTN)
Monteverde & Associates Announces the Investigation of NTN Buzztime, Inc.
Churchill Capital Corp III
(CCXX)
Monteverde & Associates Announces the Investigation of Churchill Capital Corp III
Principia Biopharma Inc.
(PRNB)
Monteverde & Associates Announces the Investigation of Principia Biopharma Inc.
